Amphastar Pharmaceuticals (DE:29A)
FRANKFURT:29A
Holding DE:29A?
Track your performance easily

Amphastar Pharmaceuticals (29A) Income Statement

0 Followers

Amphastar Pharmaceuticals Income Statement

Last quarter (Q3 2024), Amphastar Pharmaceuticals's total revenue was $191.21M, an increase of 5.90% from the same quarter last year. In Q3, Amphastar Pharmaceuticals's net income was $40.43M. See Amphastar Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 723.55M$ 644.39M$ 498.99M$ 437.77M$ 349.85M$ 322.36M
Cost of Revenue
$ 340.20M$ 293.27M$ 250.13M$ 24.60M$ 13.90M$ 9.40M
Gross Profit
$ 383.35M$ 351.12M$ 248.86M$ 199.74M$ 143.34M$ 131.92M
Operating Expense
$ 169.09M$ 154.13M$ 141.36M$ 129.85M$ 132.39M$ 131.96M
Operating Income
$ 214.25M$ 196.99M$ 107.50M$ 69.89M$ 10.95M$ -39.00K
Net Non Operating Interest Income Expense
$ -7.44M$ -21.70M$ -525.00K$ -284.00K$ 268.00K$ 878.00K
Other Income Expense
$ -76.56M$ -3.93M$ 242.24M$ -14.33M$ 6.58M$ 131.04M
Pretax Income
$ 187.15M$ 171.36M$ 116.04M$ 84.14M$ 4.64M$ 60.23M
Tax Provision
$ 28.35M$ 31.83M$ 23.48M$ 20.63M$ 3.54M$ 13.72M
Earnings From Equity Interest Net Of Tax
$ -1.08M$ -1.98M$ -1.18M$ -208.00K--
Net Income Common Stockholders
$ 157.72M$ 137.54M$ 91.39M$ 62.12M$ 1.40M$ 48.94M
Basic EPS
------
Diluted EPS
------
Basic Average Shares
------
Diluted Average Shares
------
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 363.78M$ 447.41M$ 158.56M$ 154.45M$ 146.29M$ 141.36M
Net Income From Continuing And Discontinued Operation
$ 157.72M$ 137.54M$ 91.39M$ 62.12M$ 1.40M$ 48.94M
Normalized Income
$ 107.55M$ 138.07M----
Interest Expense
------
EBIT
$ 204.64M$ 198.52M$ 117.89M$ 323.05M$ 5.01M$ 60.35M
EBITDA
$ 266.28M$ 240.29M$ 146.16M$ 111.56M$ 30.19M$ 81.50M
Currency in USD

Amphastar Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis